Exchange-traded funds (ETFs) are no longer just about tracking the biggest indices. Some of the most interesting opportunities today sit in funds that tilt portfolios in a particular direction, whether that’s toward momentum, value, or overlooked regions.

If you’re looking beyond the usual suspects, here are three ASX ETFs that could be worth a closer look.

Betashares Australian Momentum ETF (ASX: MTUM)

The first ETF that stands out is the Betashares Australian Momentum ETF.

Instead of trying to predict which company will perform next, this fund simply follows the money. It invests in Australian shares that have demonstrated strong recent price momentum, meaning it systematically tilts toward what is already working.

This approach may not sound sophisticated, but momentum has been one of the most persistent factors in markets globally. When trends take hold, they often last longer than investors expect. The ASX ETF captures that by rebalancing regularly and letting performance guide allocations.

For investors who prefer rules over instincts, this can be a surprisingly effective way to stay aligned with market leadership without constantly making judgement calls. It was recently recommended by the team at Betashares.

VanEck MSCI International Value ETF (ASX: VLUE)

Another ETF worth considering is the VanEck MSCI International Value ETF.

Global markets have been dominated by growth and technology stocks for years, but value cycles tend to reappear when least expected. This fund focuses on international shares that are trading at attractive valuations based on fundamentals such as earnings and cash flow.

Rather than betting on high-growth narratives, this ETF tilts toward established global businesses that may be out of favour but remain structurally important. In periods where investors rotate away from expensive growth stocks, value exposure can provide balance.

This ASX ETF can therefore act as both a diversification tool and a contrarian tilt in portfolios heavily weighted toward high-multiple sectors. This fund was recently recommended by analysts at VanEck.

Betashares MSCI Emerging Markets Complex ETF (ASX: BEMG)

A third ASX ETF that could be a best buy for investors looking further afield is the Betashares MSCI Emerging Markets Complex ETF.

Emerging markets are often viewed as volatile and unpredictable. This fund takes a more refined approach by focusing on emerging market companies with stronger governance, higher quality characteristics, and more resilient business models.

Instead of simply tracking the largest emerging market stocks, it attempts to filter for sustainability and financial strength. This can reduce exposure to weaker state-owned enterprises and tilt toward businesses benefiting from rising middle classes, digital adoption, and industrial development.

For investors wanting emerging market exposure without diving blindly into risk, the Betashares MSCI Emerging Markets Complex ETF offers a more measured way in. It was also recently recommended by Betashares.

The post Why these ASX ETFs could be best buys appeared first on The Motley Fool Australia.

More reading

• Want to invest in the best stocks in the world? Try these ASX ETFs
• Where to invest $10,000 in ASX ETFs
• 5 excellent ASX ETFs to buy now
• Where to invest $10,000 in ASX ETFs right now
• The best ASX ETFs to buy for an SMSF

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

When I look for blue-chip ASX 200 shares to buy, I am looking for businesses that I believe have clear drivers of growth and the ability to deliver solid returns over time.

Right now, these are three S&P/ASX 200 Index (ASX: XJO) shares I think are top buy-and-hold options for blue-chip investors.

Goodman Group (ASX: GMG)

What I like about Goodman Group is that it never stands still. It consistently positions itself around powerful structural trends.

The company develops and manages high-quality industrial property and data centres in major cities around the world. Demand for logistics facilities remains supported by ecommerce, while the growth of cloud computing and artificial intelligence is driving significant interest in data centre developments.

Goodman’s model allows it to partner with institutional capital, recycle assets, and reinvest in new projects. I like that this flexibility supports long-term growth while helping to manage risk.

Although the shares are not cheap, the company’s global footprint and exposure to long-term infrastructure demand make it a compelling option in the ASX 200.

Qantas Airways Ltd (ASX: QAN)

Qantas offers a different kind of opportunity.

Airlines are inherently cyclical businesses, but Qantas has strengthened its position in recent years through cost discipline, network optimisation, and a strong domestic market share. Travel demand has remained resilient, particularly in premium and international segments.

The company’s loyalty program also provides a valuable earnings stream that is not exposed to fuel prices and short-term travel fluctuations.

While Qantas shares can be volatile, the combination of improved operational focus and strong brand recognition makes it a stock I would consider buying at the right price.

Macquarie Group Ltd (ASX: MQG)

Macquarie is a blue-chip ASX 200 share that offers diversification and global exposure.

Unlike traditional banks, Macquarie operates across asset management, infrastructure, commodities, and advisory services. That mix of businesses helps smooth earnings through different economic conditions.

Macquarie has a long history of adapting its business model, investing in new opportunities, and maintaining balance sheet strength. Its exposure to infrastructure and energy transition themes also provides longer-term growth potential.

For investors seeking exposure to financial services with a global edge, I think Macquarie remains one of the more compelling shares on the ASX 200.

Foolish takeaway

Goodman, Qantas, and Macquarie operate in very different sectors, but each has identifiable drivers that I believe could support performance over time.

For investors looking within the ASX 200, these three shares offer a mix of infrastructure-backed growth, cyclical recovery potential, and diversified financial services exposure.

The post 3 blue-chip ASX 200 shares I would buy and hold appeared first on The Motley Fool Australia.

More reading

• The $10,000 Test: Which ASX shares would I still own after 10 years?
• How I would build an income portfolio that lasts a lifetime
• Here are the top 10 ASX 200 shares today
• Buy, hold, sell: Evolution Mining, HomeCo, and Macquarie shares
• Where to invest $10,000 in ASX growth shares

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It was another busy week for Australia’s top brokers. This has led to the release of a number of broker notes.

Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

Electro Optic Systems Holdings Ltd (ASX: EOS)

According to a note out of Ord Minnett, its analysts have retained their speculative buy rating and $12.72 price target on this defence technology company’s shares. The broker notes that EOS was the subject of a short seller attack from Grizzly Reports. It was pleased with management’s response to the report and appreciates the improved clarity on existing contracts. Overall, Ord Minnett remains positive on the investment opportunity here and highlights that EOS stands to benefit from geopolitical tensions and rising defence spending. It also points out that the company has a substantial unconditional order book. The EOS share price ended the week at $5.86.

PLS Group Ltd (ASX: PLS)

A note out of Macquarie reveals that its analysts have upgraded this lithium miner’s shares to an outperform rating with an improved price target of $5.00. The broker made the move after making a significant upgrade to its lithium price forecasts for 2026. Macquarie is now materially more positive on spodumene and is expecting a price of US$1,800 per tonne this year. This is notably higher than PLS’ unit operating costs per tonne, which will be a big boost to profitability. As a result, it has lifted its earnings per share estimates and valuation accordingly and sees plenty of value on offer here for investors. The PLS share price was fetching $4.23 at Friday’s close.

Pro Medicus Ltd (ASX: PME)

Analysts at Bell Potter have retained their buy rating on this health imaging technology company’s shares with a reduced price target of $240.00. This follows the release of Pro Medicus’ half-year results, which it concedes were a touch short of expectations. Bell Potter notes that although it delivered a record result with strong revenue and profit growth, its revenue was still a 5% miss. Outside this, the broker highlights that management believe AI will disrupt its business. Bell Potter agrees with this view and believes that Pro Medicus is well-placed to benefit from increasing demand for radiology services. This is especially the case given how its systems remain a driver of efficiency in radiology. Overall, the broker thinks that following recent weakness among software stocks, an attractive entry point has opened up for investors. The Pro Medicus share price ended the week at $118.22.

The post Top brokers name 3 ASX shares to buy next week appeared first on The Motley Fool Australia.

More reading

• 2 ASX shares I’d buy after seeing their results this week!
• Should you just forget ASX tech stocks after the AI selloff?
• Recap: Winners and losers from earnings season week 2
• Bell Potter names 3 sold-off ASX 200 shares to buy today
• Brokers name 3 ASX shares to buy today

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems and Macquarie Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

With interest rates rising, income investors are understandably focused on yield.

But while term deposits may offer more than they did a few years ago, there are still ASX shares providing attractive forward yields, with the added benefit of potential capital growth.

Based on broker forecasts, the following four shares combined offer an average forward dividend yield of around 6%. Here’s what analysts are saying about them:

APA Group (ASX: APA)

The first ASX share to consider is APA Group. It owns and operates a portfolio of gas pipelines, storage facilities, and energy infrastructure assets across Australia. These assets are typically backed by long-term contracts, providing visible cash flow and supporting reliable distributions.

Macquarie is positive on the company and currently has an outperform rating and $9.23 price target on its shares. As for income, the broker is forecasting a dividend yield of approximately 6.4% in FY 2026.

Aurizon Holdings Ltd (ASX: AZJ)

Another ASX share worth considering for dividends is Aurizon. It operates one of Australia’s largest rail freight networks, transporting bulk commodities such as coal across key export corridors. While volumes can fluctuate, much of the company’s revenue is underpinned by long-term take-or-pay contracts.

Macquarie is also positive on this one. The broker recently put an outperform rating on Aurizon’s shares with a $3.77 price target.

With respect to dividends, the broker is expecting the company’s shares to deliver a yield of around 5.4% in FY 2026.

Dexus Industria REIT (ASX: DXI)

For investors wanting property exposure, the Dexus Industria REIT could be worth a closer look according to analysts. It focuses on industrial assets, including warehouses and logistics facilities, which continue to benefit from structural trends such as ecommerce and supply chain optimisation.

Bell Potter is feeling positive about the company’s outlook. It recently put a buy rating and $3.00 price target on the ASX share.

As for that all-important income, the broker is forecasting a dividend yield of approximately 6.6% in FY 2026, making it one of the higher-yielding names in this group.

Premier Investments Ltd (ASX: PMV)

The final ASX share to consider for income is Premier Investments. It is the owner of popular retail brands Smiggle and Peter Alexander, as well as a stake in Breville Group Ltd (ASX: BRG). These assets are consistently generating strong free cash flow, which is usually returned to shareholders in the form of dividends.

Macquarie is also positive on this one. It currently has an outperform rating and $16.20 price target on the shares.

As for income, the broker expects a fully franked dividend yield of approximately 5.8% in FY 2026.

The post 4 ASX shares to consider buying with an average dividend yield of 6% appeared first on The Motley Fool Australia.

More reading

• Income investors are watching these 3 ASX REIT results. Here’s the details
• Forget BHP shares! Buy these ASX dividend shares instead for passive income
• 3 defensive ASX dividend shares that analysts are tipping as top buys
• Is this the right time to invest in ASX defensive shares?
• 3 top ASX energy stocks dividend investors should watch

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Apa Group and Macquarie Group. The Motley Fool Australia has recommended Premier Investments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Every now and then, I like to run a simple thought experiment.

If I invested $10,000 today and was not allowed to sell, check, or tweak the portfolio for the next decade, which ASX shares would I feel comfortable locking away?

It is an unforgiving test. It removes the ability to react. No trimming positions. No rotating into the latest trend. No panic selling.

Only businesses strong enough to justify long-term trust make the cut.

Here are three ASX shares that pass that test for me.

Sigma Healthcare Ltd (ASX: SIG)

Sigma makes the list because of the essential nature of what it does.

Following its merger with Chemist Warehouse, this ASX share now sits at the centre of a large pharmacy distribution and retail network. Medicines and pharmacy services are not discretionary purchases. Demand tends to be steady regardless of economic conditions.

What gives me confidence over a 10-year period is scale. A nationwide distribution footprint, established supplier relationships, and strong retail brands create a business that is embedded in Australia’s healthcare system.

The healthcare sector will evolve, but access to medicines and pharmacy services will remain critical. That makes Sigma the kind of stock I would feel comfortable owning through multiple cycles.

Goodman Group (ASX: GMG)

Goodman passes the decade test for a different reason.

Its assets sit at the centre of structural shifts in the global economy. Logistics facilities support ecommerce. Data centres underpin cloud computing and artificial intelligence (AI). These are not short-lived trends.

Goodman’s development-led model allows it to partner with institutional capital while recycling funds into new projects. That creates a growth engine tied to infrastructure demand rather than short-term retail cycles.

Over 10 years, I would back well-located, well-managed industrial and data infrastructure to remain relevant.

TechnologyOne Ltd (ASX: TNE)

TechnologyOne is a bold call in the current environment with investors panicking about AI disruption.

But enterprise software is deeply embedded across government, education, and large organisations. These customers rarely switch systems lightly, let alone let AI run wild on their computers. 

If I had to ignore my portfolio for 10 years, I would want exposure to businesses that customers rely on every single day. I think TechnologyOne ticks this box. 

Why this test matters

Most investors underestimate how powerful long holding periods can be.

The more often we intervene, the more likely we are to interrupt compounding. By asking which ASX shares we would hold without touching, we naturally filter for quality, durability, and structural growth.

The exercise also forces discipline. It reduces the temptation to chase momentum and refocuses attention on businesses with staying power.

Foolish takeaway

We cannot actually lock our portfolios away for 10 years. Markets move. Circumstances change.

But asking which ASX shares we would feel comfortable owning for a decade is revealing. It highlights businesses with durable demand, strong competitive positions, and management teams capable of navigating change.

For me, Sigma Healthcare, Goodman Group, and TechnologyOne are the kinds of ASX shares that could pass that test.

The post The $10,000 Test: Which ASX shares would I still own after 10 years? appeared first on The Motley Fool Australia.

More reading

• How I would build an income portfolio that lasts a lifetime
• Here are the top 10 ASX 200 shares today
• 13 ASX 200 shares hit multi-year lows as the market takes a breather
• Buy, hold, sell: Telstra, TechnologyOne, NAB shares
• Best ASX stock to buy right now: Xero or TechnologyOne?

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group and Technology One. The Motley Fool Australia has recommended Goodman Group and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Commonwealth Bank of Australia (ASX: CBA) share price has had a great month to date, rising by more than 17% (at the time of writing). Investors loved the FY26 half-year result that the ASX bank share revealed.

However, while the numbers were pleasing, not every analyst is impressed enough to think that Australia’s biggest bank is a buy.

Let’s take a look at what broker UBS thought of the result and the appeal of the bank’s valuation.

UBS commentary on the ASX bank share

The broker noted that the HY26 result beat both UBS’ forecast and market expectations by about 5%. Loan growth helped deliver a good performance with “strong” net interest income, despite a weaker-than-expected net interest margin (NIM) (the profit margin on its lending, which includes the cost of funding the loans).

CBA achieved cash net profit after tax (NPAT) of $5.4 billion and declared an interim dividend per share of $2.35.

Underlying costs grew by 5.3% half over half, with a lower credit charge supporting 5% profit growth.

UBS highlighted a few different things in the result, with the business banking division being a “standout” with 8.7% growth half over half.

The broker also noted the growth in transactional deposits, particularly in retail banking (11.6%), because this widens CBA’s economic moat in the retail market, supporting both the group net interest margin and net interest income.

UBS also said that CBA’s mortgage business is in “full swing” with a record value of new business written in the half.

The stronger-than-anticipated lending growth is expected to “support cash NPAT growth in a stable asset quality and credit environment despite a fluid competitive backdrop”.

Is the CBA share price attractive?

UBS has a sell rating on the ASX bank share, with a price target of $130, which implies a possible decline of more than 20% over the next year.

Despite the increase in earnings per share (EPS) estimates, UBS said that it finds the CBA share price valuation “challenging”. The broker expects EPS to grow at a compound annual growth rate (CAGR) of around 4% in the next three years.

UBS noted that CBA is trading significantly above its historical price-to-book (P/B) ratio and price-to-earnings (P/E) ratio.

The broker now estimates that CBA could generate a net profit of $10.8 billion in the 2026 financial year and $11.1 billion in the 2027 financial year.

The post The CBA share price is a sell – UBS appeared first on The Motley Fool Australia.

More reading

• How I would build an income portfolio that lasts a lifetime
• 3 ASX ETFs for investors chasing yield and growth
• Recap: Winners and losers from earnings season week 2
• Brokers re-rate CBA and ANZ shares after banks stun the market
• ASX shares with ex-dividend dates next week

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The iShares S&P 500 ETF (ASX: IVV) is one of the leading exchange-traded funds (ETFs) to consider for the long-term, in my view.

I’m not just saying that because it has performed strongly over the past several years – it has returned an average of 15.4% over the prior decade. Past performance is not a guarantee of future returns of course.

But, there are a few reasons why I think it’s a great time to invest.

Lower valuation

As the chart below shows, at the time of writing, the IVV ETF had actually fallen by 7% since 12 November 2025.

There has been significant volatility in the last few months for the US share market, with AI worries hitting certain businesses, as well as a strengthening of the Australian dollar against the US dollar.

On 12 November, A$1 was equivalent to 65 US cents and it’s now 71 US cents. In my view, that makes it a better time to invest in US businesses and US earnings.

When prices fall of great businesses, I get excited about the opportunity. It’s not often that the IVV ETF falls as much as it has. It’s always possible it could drop further.

The businesses continue to be at the forefront

If an Aussie investor wants to gain exposure to many of the world’s greatest businesses, all in one place, then the iShares S&P 500 ETF is one of the leading options.

It provides exposure to 500 of the largest and most profitable businesses listed in the US. That includes names like Nvidia, Apple, Microsoft, Amazon, Alphabet, Broadcom, Meta Platforms and Berkshire Hathaway.

Many of these businesses are driving the technology space forwards with semiconductors, AI, cloud computing, social media, smartphones, e-commerce and much more. It’s these areas that are likely to drive earnings higher and help push the share prices higher.

I’m not expecting every single business to perform strongly forever, but new businesses can come up the holdings list and continue to make the IVV ETF one of the best ASX ETFs to hold.

Ultra-low fees

It’s not just its great holdings that make this investment so appealing. There’s also the fact that it’s one of the cheapest ASX ETFs available to Australian investors.

The IVV ETF has an annual management fee of just 0.04%, which is incredibly low and means virtually of the gross returns generated stay with investors each year. That makes it a very effective choice for wealth building with such low costs and providing exposure to wonderful businesses.

The post Why this could be a great time to invest in the iShares S&P 500 ETF (IVV) appeared first on The Motley Fool Australia.

More reading

• 3 amazing ASX ETFs you need to know
• Why these ASX ETFs could be perfect for buy and hold investors
• 3 ASX ETFs to buy and hold for 25 years
• What’s the likelihood of a stock market crash before the end of 2026?
• Is this the best ASX ETF to buy to build wealth?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, Nvidia, and iShares S&P 500 ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Broadcom. The Motley Fool Australia has recommended Alphabet, Amazon, Apple, Berkshire Hathaway, Meta Platforms, Microsoft, Nvidia, and iShares S&P 500 ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The team at Morgans was busy running the rule over the results of a number of popular ASX stocks last week.

Let’s see how three big names fared after the broker reviewed their updates. Are they buys, holds, or sells?

ANZ Group Holdings Ltd (ASX: ANZ)

Morgans concedes that ANZ’s first-quarter update implies that it is trading ahead of expectations during the first half of FY 2026.

However, it notes that this was driven by cost reductions. So, with management retaining its cost guidance for the full year, it isn’t getting overly excited by the update.

In fact, due to valuation reasons, the broker has downgraded ANZ shares to a sell rating with a slightly improved price target of $32.65. It said:

On face of it, the 1Q26 trading update suggested ANZ was tracking ahead of 1H26 growth expectations.  However, the beat was driven mostly by the speed of cost-out and will unlikely affect consensus expectations as ANZ retained its FY26 cost guidance of c.$11.5bn. We make minor adjustments to FY26-28F EPS, reflecting 1Q26 Markets revenue strength, impairment charges lower than expected (but off an already low base), and higher shares on issue (DRP uptake was higher than assumed). 12-month target price $32.65 (+8 cps).

We estimate ANZ is trading on 1.8x P:TBV, 16x PER, and 4.1% cash yield (partly franked), all stretched against historical trading ranges. Given the recent share price strength, we downgrade our rating from TRIM to SELL with a potential TSR of -15%.

Breville Group Ltd (ASX: BRG)

Morgans was pleased with this appliance manufacturer’s half-year results and particularly its operational execution in a difficult environment. In light of this, the broker has retained its buy rating with an improved price target of $40.65. It explains:

1H26 was better-than-feared, with double-digit sales growth (+10%) largely offset by tariff costs (~130bp GM impact) to deliver a flat NPAT outcome (+1% on pcp). Crucially, FY26 EBIT growth guidance provides much-needed earnings visibility, alleviating some concerns for an extended transition year and improving our confidence for a resumption of sustainable EPS growth from FY27+.

We continue to be impressed by BRG’s strong operational execution, green shoots in Food Prep, and powerful medium-term tailwinds (geographic expansion, espresso tailwinds, NPD, Best Buy developments). Buy maintained.

South32 Ltd (ASX: S32)

Lastly, diversified mining giant South32 delivered a first-half profit result and dividend that was ahead of the market’s expectations.

But due to a recent share price surge, the broker has been forced to downgrade South32’s shares to an accumulate rating (from buy) with an unchanged price target of $5.00. It explains:

Bumper 1H26 EBITDA comfortably ahead of consensus and close to our estimate, riding consistent production and higher base and precious metals. 15% interim dividend beat and upsized capital management of an extra US$100m. Not all positive, Hermosa budget increase flagged for H2 a ST risk to monitor. Guidance unchanged, besides Brazil Aluminium output and capex timing tweaks.

We lower our rating to ACCUMULATE (from BUY) with an unchanged A$5.00 TP, recommending patience when adding following the recent share price surge.

The post Buy, hold, sell: ANZ Bank, Breville, South32 shares appeared first on The Motley Fool Australia.

More reading

• Here’s an ASX 200 share that I think could beat Westpac in 2026
• Recap: Winners and losers from earnings season week 2
• Brokers re-rate CBA and ANZ shares after banks stun the market
• Brokers name 3 ASX shares to buy today
• What’s going on with ASX bank stocks this week?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

It’s been an interesting time for ASX mid-cap stocks of late. We’re seeing some mid-caps outperform the broader market and with business spending predicted to continue picking up in 2026, many are poised for growth.

And it makes sense that this market is getting more attention. Mid-caps often have more resilience than their smaller counterparts and potentially more runway for growth than their larger ones.

Here are three that are worth adding to your watchlist.

Megaport Ltd (ASX:MP1)

Megaport may not be the most exciting name in AI tech right now, but it is a pivotal one. This Network-as-a-Service provider facilitates connectivity between data centres, cloud services and corporate networks with an on-demand model that allows business to access the bandwidth needed at any given point.

Its share price has been a little volatile of late, down over 10% in the last month, potentially due to some investor caution about its relatively high price-to-sales ratio and broader weakness in the tech sector.

However, Megaport delivered solid results in FY25 and has some strong, tailwinds, with the surge in AI usage driving demand for fast, low-latency interconnection.

In FY25, it reported 20% growth in Annual Recurring Revenue (ARR), 16% growth in total revenue ($227.1 million) and an 18% lift in large customers. And it is moving forward with a compute-as-a-service arm through the acquisition of Latitude.Sh, a play that will expand its global reach and capability.  

Although recent indicators are positive, right now, this might be a buy for investors with a slightly higher risk tolerance than me. But I do think there is potential value here. I’m adding it to my watchlist with a sneaking suspicion that it might be one I later regret not jumping on.

HUB24 Ltd (ASX: HUB)

While this stock has gained more attention recently, for me, it deserves still more of the spotlight. At current prices, I believe it’s conservatively valued and poised for growth.

HUB24 is an Australian investment and superannuation platform, delivering technology solutions to the financial advice sector. It offers a range of cloud-based and platform products to accountants, wealth advisers and financial planners, from compliance to reporting.

It’s been recognised as the overall market leader in platform functionality in successive Investment Trends annual benchmarking reports. And it is an industry favourite with rapidly growing funds under management, reporting record quarterly net inflows of $5.6 billion in Q2 FY26. 

The quality of its platform is fast creating a competitive moat for this local tech success story, particularly as the financial advice industry faces ever more complex regulation.  

In FY25, it posted revenue of $406.6 million, representing 24% year-on-year growth. In addition, it’s underlying EBITDA margin grew to 39.9%, indicating solid operating leverage.

Its share price is sitting at $76.57, down from a 12-month high of $122.03, making now an attractive entry point for investors. 

Objective Corporation Ltd (ASX: OCL)

Objective is another player in the tech space that is perhaps not garnering as much attention as it deserves. It delivers mission-critical technologies to government and enterprise, everything from planning tech for local councils to disclosure management software for HUB24.

It has seen some share price decline over the last year, down circa 15%, driven by the broader pullback across the tech sector. Investors may also be cautious about its reliance on heavily regulated industries in the current climate.

That said, I think Objective is primed for growth.

In FY25, it reported:

• A 15.1% jump in ARR to $120 million
• Net profit after tax growth of 13% to $35.4 million
• Total dividends of 22 cents per share

It has a solid defensive moat, too, being embedded in large-scale government and defence clients. And it has demonstrated a commitment to constant innovation with a healthy investment in research and development in FY25.

Objective is attractively priced right now. And, in my opinion, it’s one to consider for long-term investors who are prepared for the prospect of some shorter-term volatility.    

The post ASX tech mid-cap stocks to watch this earnings season appeared first on The Motley Fool Australia.

More reading

• 13 ASX 200 shares hit multi-year lows as the market takes a breather
• A once-in-a-decade chance to buy ASX 200 tech stocks like WiseTech, Megaport and NextDC?
• 3 of the best Australian stocks to buy and hold until 2036
• My 10 best ASX shares to buy in February
• Where I would invest $10,000 in ASX 200 shares in February

Motley Fool contributor Melissa Maddison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24, Megaport, and Objective. The Motley Fool Australia has positions in and has recommended Objective. The Motley Fool Australia has recommended Hub24. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Reporting season is in full swing, and I’m seeing a lot of opportunities as share prices shift across the ASX share market.

When businesses are growing quickly, but they’re undervalued, there’s room for very good returns, in my eyes.

I think the two ASX shares below can outperform the S&P/ASX 200 Index (ASX: XJO) over the next few years.

Pro Medicus Ltd (ASX: PME)

The medical imaging software business has suffered a massive sell-off despite the ongoing financial success of the business. In the last month, it’s down more than 40% and the past six months show a decline of around 60%, as the chart below shows.

That’s an incredible decline for a business that has been one of the most impressive ASX share performers over the long term.

The FY26 half-year result was very solid. Revenue rose 28.4% to $124.8 million, and underlying profit before tax grew 29.7% to $90.7 million.

Incredibly, the underlying operating profit (EBIT) margin continues to improve – it rose to 73%, up from 72%. I don’t know how high it can rise, but the company’s bottom line looks like it has a very promising outlook.

It continues winning new, large contracts in the US, and this is helping drive the company’s financials higher. Also, it’s selling more modules to existing clients and winning cardiology contracts.

I don’t think AI will hurt Pro Medicus as much as some investors expect. It could help Pro Medicus in some ways if it leads to better/faster software development, or better features.

The company said its pipeline remains “very strong”. According to the forecast on CMC Invest, it’s currently valued at just 80x FY26’s estimated earnings, which is significantly smaller than it was before.

Centuria Industrial REIT (ASX: CIP)

The other ASX share I want to highlight is this real estate investment trust (REIT), which focuses on owning industrial properties across Australia in urban areas where demand is strong and supply is limited.

The industrial REIT reported that in the six months to 31 December 2025, it delivered 5.1% like-for-like net operating income growth. Rental income is being driven by increasing demand from population growth, e-commerce adoption, refrigerated space requirements (for food and medicine), and data centres.

With the result, the fund manager of the REIT, Grant Nichols, said:

CIP maintains significant earnings upside due to its strong, anticipated medium-term income growth resulting from material under-renting across the portfolio, expected improved portfolio occupancy, prudent completed capital management and the expected market rental growth stemming from Australia’s favourable industrial market conditions. Improving tenant demand and constrained supply is expected to drive the national vacancy to less than 2.0% by 2030, providing a pathway to continued strong market rental growth.

It reported its net tangible assets (NTA) per unit grew slightly to $3.95 during the six-month period, suggesting it’s trading at a discount of 19% at the time of writing.

The post 2 ASX shares I’d buy after seeing their results this week! appeared first on The Motley Fool Australia.

More reading

• Should you just forget ASX tech stocks after the AI selloff?
• Recap: Winners and losers from earnings season week 2
• Bell Potter names 3 sold-off ASX 200 shares to buy today
• Here are the top 10 ASX 200 shares today
• Brokers name 3 ASX shares to buy today

Motley Fool contributor Tristan Harrison has positions in Pro Medicus. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.